Vascular Post Market Review

Completed

Conditions studied: Carotid Endarterectomy

In brief

The primary objective of this study is to confirm that properties of CardioCel provide operative benefit to surgeons when compared to Dacron, CorMatrix, and all other bovine pericardium not treated with proprietary ADAPT engineering.

Key facts

Study ID

NCT02681341

Run by

Baylor Research Institute

People needed

10

Starts

2016-02-01

Expected to finish

2017-09-21

Last updated by the study team

2017-10-26

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Scheduled for carotid endarterectomy (CEA) with patch arterioplasty
• Expected lifespan of over 24 months
• Age over 18 years

You may not qualify if…

• Revision of previous CEA arterioplasty
• Active infection
• Cerebral ischemic event (completed stroke) within 30 days of planned surgery
• Pregnant or breastfeeding
• Concomitant surgical or endovascular procedure being performed

Where it is running

• The Heart Hospital Baylor Plano — Plano, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.